Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
04/2010
04/15/2010US20100093642 Novel polypeptides
04/15/2010US20100093641 Silk protein-mimicking peptides and compositions for preventing or treating cranial neuropathies comprising the same
04/15/2010US20100093640 Ace-inhibitory peptides from whey and methods for providing the same
04/15/2010US20100093639 Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides
04/15/2010US20100093637 Peptides and use thereof
04/15/2010US20100093635 Agonists of Guanylate Cyclase UseFul For The Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
04/15/2010US20100093634 Methods for regulating urinary potassium
04/15/2010US20100093630 Mammalian chemokines; related reagents
04/15/2010US20100093624 Peptide therapeutics that bind vegf and methods of use thereof
04/15/2010US20100093623 Compositions and methods for modulating nod-like receptor activity and uses thereof
04/15/2010US20100093615 Antibacterial compounds and processes for its production
04/15/2010US20100093600 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions
04/15/2010US20100092941 32142,21481,25964,21686, Novel dehydrogenase molecules and uses therefor
04/15/2010US20100092500 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes
04/15/2010US20100092467 Prevention of tissue ischemia, related methods and compositions
04/15/2010US20100092458 Regulation of apg8 phosphorylation and uses thereof
04/15/2010CA2743361A1 Methods and systems for predicting misfolded protein epitopes
04/15/2010CA2737924A1 Methods of treating inflammation
04/14/2010EP2175022A1 Methods of construction biodiverse gene fragment libraries
04/14/2010EP2175013A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
04/14/2010EP2174957A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
04/14/2010EP2174948A1 Antiviral polypeptides
04/14/2010EP1521841B1 Method for identifying individual active entities from complex mixtures
04/14/2010EP1207199B1 Tumor antigen
04/14/2010EP0964693B1 Novel bacteriocins, transport and vector system and method of use thereof
04/14/2010CN1360592B Streptogramin derivs., production thereof and composition containing same
04/14/2010CN101693738A Method for synthesizing terlipressin by solid-phase oxidization and cyclization
04/14/2010CN101693737A Cornu-like polypeptide with antioxidant activity, separation method and application thereof
04/14/2010CN101693736A Novel peptides
04/14/2010CN101693672A Peptidomimetic protease inhibitors
04/13/2010US7696338 Immunotoxin fusion proteins and means for expression thereof
04/13/2010US7696307 inhibiting cell growth and metastasis and treat cancer ; A Disintegrin And Metalloproteinase with ThromboSpondin motifs (ADAMTS)
04/13/2010US7696173 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis
04/13/2010US7696152 For modulating immune activity, hepatitis infections, the extent of nephritis, and the growth of a cancer
04/13/2010US7695977 very early marker of fertilization and embryo viability; binds to anti-CD2 antibody; Infertility ; determining embryo viability
04/13/2010US7695715 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
04/13/2010US7695713 Isolation and identification of T cells
04/13/2010CA2077154C Hcmv-specific peptides, agents therefor and the use thereof
04/08/2010WO2010039461A2 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
04/08/2010WO2010039088A1 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds
04/08/2010WO2010038220A1 Peptide sequences, their branched form and use thereof for antimicrobial applications
04/08/2010WO2010038027A1 Immunogenic peptides and uses thereof
04/08/2010WO2010037351A1 Peptide antagonist of interleukin-15 activity
04/08/2010WO2010037284A1 Polypeptides for treating or preventing cancers, the derivative products and uses thereof
04/08/2010WO2009155556A3 Crkl targeting peptides
04/08/2010WO2009149675A3 Pseudacyclin and method of indication of a fungus pseudallescheria boydii
04/08/2010US20100088783 Nucleic acid molecules encoding sucrose synthase-like polypeptides and methods of use
04/08/2010US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
04/08/2010US20100087380 Pharmaceutical compositions for inhibiting intestinal permeability
04/08/2010US20100087376 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
04/08/2010US20100087005 Auxiliary reagent for gene transfer
04/08/2010US20100086563 Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl)
04/08/2010US20100086552 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens
04/08/2010DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors
04/08/2010DE102005031755B9 Salmonella spp. Salmonella spp. bindende Peptide, dafür kodierende Nukleinsäuren, deren Verwendungen und Verfahren und Kits zur Anreicherung, Immobilisierung und zum Nachweis von Salmonella spp. binding peptides, nucleic acids encoding, uses thereof and methods and kits for enrichment, immobilization and detection of Salmonella spp.
04/08/2010CA2739418A1 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
04/08/2010CA2738744A1 Peptide antagonist of interleukin-15 activity
04/07/2010EP2172546A1 Process for the deacylation of cyclic lipopeptides
04/07/2010EP2172476A2 Compositions and methods for WT1 specific immunotherapy
04/07/2010EP2172475A1 Novel lipid peptide and hydrogel
04/07/2010EP2172474A1 Novel peptide and pharmaceutical use of the same
04/07/2010EP2172210A1 Synthetic peptides for use as inhibitors of neurotransmitter secretion
04/07/2010EP2170932A1 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith
04/07/2010EP2170930A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
04/07/2010EP2170929A2 Peptides facilitating retrograde transport and their uses
04/07/2010EP2170928A1 Antibiotic peptides
04/07/2010EP2170267A1 Cationic peptide for delivering an agent into a cell
04/07/2010CN101691395A Method for solid phase synthesis of bitter gourd MC-JJ62 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ62 peptide analogs
04/07/2010CN101691394A Method for solid phase synthesis of bitter gourd MC-JJ6 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ6 peptide analogs
04/06/2010US7691968 Process for the synthesis of peptides amides by side-chain attachment to a solid phase
04/06/2010US7691967 Smart pro-drugs of serine protease inhibitors
04/06/2010US7691965 Helical synthetic peptides that stimulate cellular cholesterol efflux
04/06/2010US7691565 Comprises short polypeptide sequences for detection and recovery of antihemophilic factor; treament of blood disorders
04/06/2010US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds
04/06/2010US7691382 Antiviral polypeptides comprising tandem repeats of APOE 141-149 and variants thereof
04/06/2010CA2399676C Pharmacologically active antiviral peptides and methods of their use
04/06/2010CA2253243C Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis
04/01/2010WO2010035722A1 Peptide compound and method for producing same
04/01/2010WO2010035575A1 Melanin production inhibitor and skin-whitening cosmetic
04/01/2010WO2010035148A1 Antiviral polypeptides
04/01/2010WO2010035107A2 Peptides and compositions for prevention of cell adhesion and methods of using same
04/01/2010WO2010034787A1 Antimicrobial peptides
04/01/2010WO2010034786A1 Antimicrobial peptides
04/01/2010WO2010034784A1 Antimicrobial peptides
04/01/2010WO2010034783A1 Antimicrobial peptides
04/01/2010WO2010034490A1 Peptide uroaktivin, as an activator of the enzyme urokinase
04/01/2010WO2010034183A1 Human catechol-o-methyltransferase (comt) assay
04/01/2010WO2010017514A3 Methods of predicting cancer lethality using replikin counts
04/01/2010WO2009148252A9 Stroke-targeting peptide and use thereof
04/01/2010US20100081788 Process for the Preparation of Pramlintide
04/01/2010US20100081618 Transporters Comprising Spaced Arginine Moieties
04/01/2010US20100081612 Polypeptide derivatives of parathyroid hormone (pth)
04/01/2010US20100081611 Stabilized maml peptides and uses thereof
04/01/2010US20100081192 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
04/01/2010US20100081158 Fret protease assays for clostridial toxins
04/01/2010US20100081157 Fret protease assays for clostridial toxins
04/01/2010US20100080850 Polypeptide ligands for targeting cartilage and methods of use thereof
04/01/2010US20100080818 Expression and Characterization of HIV-1 Envelope Protein Associated with Broadly Cross Reactive Neutralizing Antibody Response
04/01/2010US20100080815 MN Gene and Protein
04/01/2010US20100080803 Labor biomarkers, methods comprising same, and methods targeting same